ABVC BioPharma, Inc.
ABVC
$1.28
$0.054.07%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 189.97% | -43.29% | 108.70% | -30.60% | 50.38% |
| Total Receivables | -71.67% | 89.45% | 164.83% | -53.50% | -5.04% |
| Inventory | -- | 0.00% | 0.00% | -- | -- |
| Prepaid Expenses | -22.51% | 129.38% | 102.28% | 0.21% | 5.37% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -2.46% | -3.82% | 13.29% | -1.30% | -2.70% |
| Total Current Assets | -38.58% | 47.00% | 88.51% | -32.58% | 1.47% |
|
|
|||||
| Total Current Assets | -38.58% | 47.00% | 88.51% | -32.58% | 1.47% |
| Net Property, Plant & Equipment | 18.70% | 43.23% | -0.32% | 655.73% | -86.36% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.01% | -1.24% | 0.73% | -0.31% | 26.49% |
| Total Assets | -0.54% | 30.39% | 9.18% | 97.29% | -47.87% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 5.09% | -1.66% | 3.28% | 1.55% | -7.20% |
| Short-term Debt | -56.49% | 33.29% | -5.02% | -6.19% | 31.93% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 95.55% | -17.88% | -48.20% | -10.26% | 0.09% |
| Total Finance Division Other Current Liabilities | -5.43% | -19.69% | 41.17% | 57.36% | 21.69% |
| Total Other Current Liabilities | -5.43% | -19.69% | 41.17% | 57.36% | 21.69% |
| Total Current Liabilities | -5.28% | -0.38% | -2.94% | 2.64% | 3.83% |
|
|
|||||
| Total Current Liabilities | -5.28% | -0.38% | -2.94% | 2.64% | 3.83% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -56.49% | 33.29% | -5.02% | -6.19% | 31.93% |
| Capital Leases | 875.44% | -7.34% | 6.05% | -29.48% | 66.53% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -71.22% | 92.17% | 0.00% | -15.56% |
| Total Liabilities | 16.18% | -1.00% | -2.43% | 1.52% | 5.13% |
|
|
|||||
| Common Stock & APIC | 3.11% | 7.80% | 3.31% | 6.39% | -9.98% |
| Retained Earnings | -4.86% | -1.73% | -3.23% | -1.22% | 2.27% |
| Treasury Stock & Other | -3.56% | -6.14% | 13.03% | -0.02% | -0.27% |
| Total Common Equity | -7.84% | 71.92% | 29.78% | 340.78% | -85.33% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -7.84% | 71.92% | 29.78% | 340.78% | -85.33% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -10.25% | -1.66% | -2.97% | 608.14% | -32.47% |
| Total Equity | -8.25% | 52.72% | 19.27% | 998.94% | -90.93% |
|
|
|||||